Literature DB >> 28939941

Kidney involvement in psoriasis: a case-control study from China.

Fang Ren1,2, Min Zhang1,2, Liying Hao1,2, Hong Sang3,4.   

Abstract

PURPOSE: Kidney involvement secondary to psoriasis is still a controversial issue. In this study, we aimed to evaluate the prevalence of urinary abnormalities in psoriasis patients and to find out whether the abnormality is related to the severity of psoriasis.
METHODS: Ninety-seven psoriasis patients (62 females, 35 males, mean age 35.74 ± 13.45 years) and ninety-six age- and gender-matched control subjects (58 males, 38 females, mean age 35.82 ± 13.48 years) without hypertension or diabetes were enrolled in this study. Psoriasis area and severity index (PASI) was used to assess the severity of psoriasis. Twenty-four-hour proteinuria, albuminuria, RBP, and NAG were measured in all patients and controls. Pathologic proteinuria was defined as the total protein excretion of more than 0.4 g/24 h, as measured by the turbidimetric assay. Pathologic albuminuria was defined as albumin excretion of more than 17 mg/24 h. Pathologic NAG and RBP were defined as the excretion of more than 16.5 u/g cr and 0.5 mg/L, respectively.
RESULTS: Increased 24-h microalbuminuria (11.53 ± 7.29 vs. 9.79 ± 3.72, P = 0.039) and 24-h proteinuria (0.24 ± 0.21 vs. 0.18 ± 0.09, P = 0.002) were found in patients with psoriasis compared with controls. Patients with psoriasis had an increased prevalence of pathological albuminuria (15.46 vs. 5.21%, P = 0.019), NAG (10.31 vs. 3.13%, P = 0.046), and RBP (9.28 vs. 2.08%, P = 0.031) compared with controls. PASI scores in patients with psoriasis correlated positively with 24-h albuminuria (χ 2 = 10.75, P = 0.005).
CONCLUSIONS: The prevalence of abnormal urinalysis was more common in patients with psoriasis than in controls. The positive correlation between the prevalence of pathological albuminuria and psoriasis severity may indicate a subclinical renal dysfunction in patients with psoriasis.

Entities:  

Keywords:  Albuminuria; Kidney involvement; Proteinuria; Psoriasis

Mesh:

Substances:

Year:  2017        PMID: 28939941     DOI: 10.1007/s11255-017-1692-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

Review 1.  Renal abnormalities in psoriatic patients: a review.

Authors:  J Heuvels; A Maximus; J L Bosmans; J Lambert; M E De Broe
Journal:  Nephron       Date:  1999       Impact factor: 2.847

2.  Renal involvement in psoriasis.

Authors:  O Kaftan; B Kaftan; M F Toppare; M Ekşioğlu
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

3.  Chronic calcineurin inhibitor nephrotoxicity-lest we forget.

Authors:  J R Chapman
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

4.  Electron microscopic studies of the microcirculation in psoriasis.

Authors:  I M Braverman
Journal:  J Invest Dermatol       Date:  1972-07       Impact factor: 8.551

5.  Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study.

Authors:  Ching-Chi Chi; Jui Wang; Yu-Fen Chen; Shu-Hui Wang; Fu-Li Chen; Tao-Hsin Tung
Journal:  J Dermatol Sci       Date:  2015-03-30       Impact factor: 4.563

6.  The spectrum of renal abnormalities in patients with psoriasis.

Authors:  Erkan Dervisoglu; Aysun Sikar Akturk; Kursat Yildiz; Rebiay Kiran; Ahmet Yilmaz
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

Review 7.  Comorbidities in psoriasis.

Authors:  Sanjeev J Aurangabadkar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2013-07       Impact factor: 2.545

8.  Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Authors:  Joy Wan; Shuwei Wang; Kevin Haynes; Michelle R Denburg; Daniel B Shin; Joel M Gelfand
Journal:  BMJ       Date:  2013-10-15

9.  Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.

Authors:  Mohamed H Mahfouz; Adel M Assiri; Mohammed H Mukhtar
Journal:  Biomark Insights       Date:  2016-02-16

10.  Evaluation of renal function in patients with psoriasis using immunobiologicals.

Authors:  Sarah Suyanne Carvalho Melgaço; Geraldo Bezerra da Silva; Amanda Maria Menezes Dantas; Ana Mirella Arcanjo Vasconcelos; Verônica Riquet de Siqueira; Ana Patrícia Freitas Vieira; Elizabeth de Francesco Daher
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

View more
  3 in total

1.  Psoriasis and Renal Disorders: A Large-Scale Population-Based Study in Children and Adults.

Authors:  Rivka Friedland; Khalaf Kridin; Arnon Dov Cohen; Daniel Landau; Dan Ben-Amitai
Journal:  Dermatology       Date:  2022-03-03       Impact factor: 5.197

2.  Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes.

Authors:  Song Wen; Congying Liu; Yanyan Li; Junhong Pan; Thiquynhnga Nguyen; Ligang Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-26       Impact factor: 3.168

3.  Proteinuria and Psoriasis Risk: A Nationwide Population-Based Study.

Authors:  Eun Hui Bae; Bongseong Kim; Su Hyun Song; Tae Ryom Oh; Sang Heon Suh; Hong Sang Choi; Chang Seong Kim; Seong Kwon Ma; Kyung-Do Han; Soo Wan Kim
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.